Business Context and Reporting Period
OrthoPediatrics Corp. filed this Form 8-K on May 14, 2018, to disclose a material event under Regulation FD. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on a regulatory milestone.
Material Changes
The primary material change reported is the receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for the Pediatric Nailing Platform | FEMUR. This approval marks the Company's 25th surgical system. The platform utilizes high-precision instruments to support two distinct pediatric-specific nail offerings.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management outlook, or specific risk factors beyond the standard disclosure that the press release is not deemed "filed" for purposes of Section 18 of the Exchange Act. No unusual items or contingencies were reported in this document.
Investor Verification Points
- Verify the commercial launch timeline for the Pediatric Nailing Platform | FEMUR.
- Confirm the specific indications and market size for the two pediatric-specific nail offerings included in the platform.
- Review the full text of the press release (Exhibit 99.1) for additional details on the FDA clearance scope.